Simon Hickling serves as Principal at Ratae Consulting, LLC, where he leverages over 25 years of international experience to drive business development and strategic partnerships across the Pharma, FoodTech, Synthetic Biology, and Biocatalysis sectors. His extensive background in identifying and closing lucrative deals has not...
Simon Hickling serves as Principal at Ratae Consulting, LLC, where he leverages over 25 years of international experience to drive business development and strategic partnerships across the Pharma, FoodTech, Synthetic Biology, and Biocatalysis sectors. His extensive background in identifying and closing lucrative deals has not only generated over $1 billion in revenues but has also positioned him as a trusted advisor in the industry. At Ratae Consulting, Simon focuses on delivering tailored consulting services that empower clients to navigate complex market landscapes, optimize their licensing strategies, and forge impactful partnerships.
Currently, Simon is spearheading key projects that involve the commercialization of innovative biotechnological solutions, emphasizing the integration of synthetic biology into traditional manufacturing processes. His expertise in technical marketing and product development allows him to effectively communicate the value propositions of cutting-edge technologies, ensuring that clients can capitalize on new business opportunities. Additionally, Simon's strategic planning skills are instrumental in guiding organizations through territory growth and account management, helping them to expand their market presence and enhance their competitive edge.
Passionate about the transformative potential of biotechnology, Simon is committed to fostering advancements that improve health outcomes and sustainability. His collaborative approach and deep understanding of active pharmaceutical ingredients (APIs) and international sales dynamics enable him to deliver actionable insights that drive success for his clients. As a thought leader in the industry, Simon Hickling continues to shape the future of biocatalysis and synthetic biology, making significant contributions to the evolution of these vital sectors.
